ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,387, issued on Aug. 26, was assigned to Alexion Pharmaceuticals Inc. (Boston).
"Compositions and methods for preparing factor Xa and derivatives" was invented by Genmin Lu (South San Francisco, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to protein sequences which can be used to generate factor Xa proteins and derivatives thereof. The protein sequences include a factor Xa light chain portion, a heavy chain catalytic domain portion, and an activation peptide C-terminal to the heavy chain catalytic domain portion."
The patent was filed on Aug. 5, 2020, under Application No. 17/629,999.
*For further informatio...